Author Index: P

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Padhani, A.
• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER
Pahle, A.
• DIAGNOSING HEART FAILURE WITH NT-PROBNP IN GENERAL PRACTICE: LOWER COSTS AND BETTER OUTCOME
Palmer, S.
• THE COST-EFFECTIVENESS OF POTENTIAL IMPROVEMENTS IN THE DIAGNOSIS OF AND TREATMENT OF DEPRESSION AMONGST PEOPLE WITH DIABETES

• PARTITIONED SURVIVAL ANALYSIS: A CRITICAL REVIEW OF THE APPROACH AND APPLICATION TO DECISION MODELLING IN HEALTH CARE

• WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?

• THE PRICE OF A CURE? ESTABLISHING THE VALUE BASED PRICE OF CAR-T CELL THERAPY FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
Papa, F. J.
• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?
Papachristou, N.
• CLINICIAN-IDENTIFIED PRIORITIES FOR MEDICATION SAFETY IN PRIMARY CARE: A PRIORITIZE STUDY
Paracha, N.
• ASSESSING THE CONTRIBUTION OF PATIENTS' PROXIMITY TO DEATH IN ECONOMIC EVALUATIONS IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER: AN EVENT BASED ANALYSIS
Parfrey, P.
• MODELLING ETELCALCETIDE EFFECTIVENESS ON HEALTH OUTCOMES: RELATING BIOCHEMICAL OUTCOMES TO MORTALITY, CARDIOVASCULAR EVENTS, FRACTURES AND PARATHYROIDECTOMY
Parker, A. M.
• RESPONSES TO NARRATIVES BY RECIPIENTS VARYING IN NUMERACY
Parpart, P.
• LESS-IS-MORE: LESS INFORMATION CAN IMPROVE CLINICAL RISK ASSESSMENT JUDGEMENTS
Paulden, M.
• A NOVEL FRAMEWORK FOR OPTIMISING THE VALUE OF PRECISION MEDICINE TECHNOLGIES

• THE COST-EFFECTIVENESS MODEL OUTPUT TOOL

• MULTI-CRITERIA DECISION ANALYSIS: USEFUL, BUT NOT A SUITABLE REPLACEMENT FOR COST-EFFECTIVENESS ANALYSIS

• METHODS DEVELOPMENT IN ECONOMIC EVALUATION INTEREST GROUP MEETING

• DECISION RULES FOR VALUE-BASED REIMBURSEMENT: MOVING ON FROM NET HEALTH BENEFIT

• TRANSFORMING THE COST-EFFECTIVENESS THRESHOLD INTO A 'VALUE THRESHOLD': INITIAL FINDINGS FROM A SIMULATION MODEL

• THE DETERMINANTS OF CHANGE IN THE COST-EFFECTIVENESS THRESHOLD

• RESOURCE ALLOCATION, VALUES AND EQUITY: MAINTAINING EQUITY IN THE FACE OF ANONYMITY

• EVALUATING THE COST-EFFECTIVENESS OF MONITORING TESTS

• PROBABILISTIC ONE-WAY SENSITIVITY ANALYSIS: A MODIFIED TORNADO DIAGRAM
Pavel, M. E.
• ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
Payne, K.
• CONSTRAINTS, CAPACITY AND CAPABILITY: AN APPLICATION OF MATHEMATICAL OPTIMISATION METHODS

• COST-EFFECTIVENESS OF RISK-BASED STRATIFIED BREAST CANCER SCREENING
Pechlivanoglou, P.
• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• DIAGNOSTIC ACCURACY OF LEVEL IV PORTABLE SLEEP TESTS VERSUS POLYSOMNOGRAPHY FOR SLEEP-DISORDERED BREATHING: A SYSTEMATIC REVIEW AND META-ANALYSIS
Pechlivanoglou, P.
• DECISION MODELLING USING R
Pedersen, K.
• COST-EFFECTIVE MANAGEMENT OF WOMEN WITH MINOR CERVICAL LESIONS: REVISITING THE APPLICATION OF HPV DNA TESTING
Pedley, A.
• BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS
Pérez-Martín, J.
• COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING IN ARAGON (SPAIN)
Peters, E.
• IMPROVING CANCER SCREENING INFORMATION: INSIGHTS FROM INDIVIDUAL DIFFERENCES IN INFORMATION PROCESSING
Peters, J.
• EXPLICIT – DEVELOPING A PLATFORM FOR ELICITING EXPERT OPINION FOR MODEL-BASED ECONOMIC EVALUATIONS

• COMPOSITE EVALUATIONS OF TESTS: MULTIPLE PRIMARY STUDIES INTEGRATED WITH AN ECONOMIC MODEL. EXPERIENCE WITH TWO CASES
Petrosyan, Y.
• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY
Petrova, D.
• DO SURGERY JOURNALS REPORT RISK REDUCTION INFORMATION IN A WAY THAT COULD PROMOTE BIAS?

• DO VISUAL AIDS IMPROVE DIAGNOSTIC INFERENCE?

• NUMERACY INFLUENCES PHYSICIANS' RISK COMMUNICATION ABOUT CANCER SCREENING
Phillippo, D. M.
• SENSITIVITY OF TREATMENT DECISIONS TO BIAS ADJUSTMENT IN NETWORK META-ANALYSIS
Piebes, M.
• THE COST OF BEING WRONG: THE IMPACT OF PREDICTION UNCERTAINTY ON THE COST-EFFECTIVENESS OF RISK-STRATIFIED STRATEGIES
Pieterse, A.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY

• ONCOLOGIST AND PATIENT QUESTIONS DURING CONSULTATIONS ABOUT ADJUVANT CANCER TREATMENT: A SHARED DECISION-MAKING PERSPECTIVE
Piringer, H.
• MONITORING PRIMARY CARE - DEVELOPMENT OF DATA BASED INDICATORS FOR THE AUSTRIAN HEALTH SYSTEM
Plotkin, S.
• IMPROVING DIAGNOSTIC DECISION MAKING FOR A RARE DISEASE: IDENTIFYING BARRIERS TO EARLY DIAGNOSIS OF SCHWANNOMATOSIS
Poon, J. L.
• STRUCTURING BENEFIT-RISK MODELS IN PRESENCE OF NUMEROUS ADVERSE EVENTS: A CASE STUDY OF MULTIPLE SCLEROSIS
Popp, J.
• EXAMINING OPTIMAL SURVEILLANCE STRATEGIES FOR PATIENTS TREATED WITH CURATIVE RESECTION FOR STAGE II OR III COLORECTAL CANCER
Popper, N.
• MONITORING PRIMARY CARE - DEVELOPMENT OF DATA BASED INDICATORS FOR THE AUSTRIAN HEALTH SYSTEM
Portielje, J.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY
Pos, F. J.
• THE EFFECT OF SALVAGE RADIOTHERAPY AND ITS TIMING ON THE HEALTH-RELATED QUALITY OF LIFE OF PROSTATE CANCER PATIENTS
Poses, R. M.
• WHY DO PHYSICIANS NOT MAKE RATIONAL, EVIDENCE-BASED DECISIONS, AND WHAT MIGHT HELP
Postma, M. J.
• POTENTIAL ECONOMIC VALUE OF BIOMARKERS IN PERSONALIZED MEDICINE: AN EXEMPLARY ASSESSMENT STUDY IN HEART FAILURE DISEASE MANAGEMENT
Postmus, D.
• POTENTIAL ECONOMIC VALUE OF BIOMARKERS IN PERSONALIZED MEDICINE: AN EXEMPLARY ASSESSMENT STUDY IN HEART FAILURE DISEASE MANAGEMENT
Postmus, D.
• STATIN BENEFIT-RISK PROFILES IN INDIVIDUALS AT INTERMEDIATE RISK FOR CARDIOVASCULAR DISEASE
Prabhu, V. S.
• BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS

• COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES

• BUDGET IMPACT OF FIDAXOMICIN COMPARED WITH VANCOMYCIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN THE UNITED STATES
Preston, L.
• THE COST-EFFECTIVENESS OF POTENTIAL IMPROVEMENTS IN THE DIAGNOSIS OF AND TREATMENT OF DEPRESSION AMONGST PEOPLE WITH DIABETES
Punwani, S.
• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z